Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low BP Vienna: SPC titration for hypertension
NCT02377661Phase 4Completed
- Sponsor
- Klinik Ottakring
- Start
- Mar 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of olmesartan, amlodipine and hydrochlorothiazide in hypertension (HTN), sponsored by Klinik Ottakring. Primary endpoint: Achievement of target office blood pressure (< 140/90 mmHg) at 6 months. Started Mar 2015; status: completed.
02
Drugs
olmesartanamlodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02377661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377661.